Exercise protects against methamphetamine-induced aberrant neurogenesis.
While no effective therapy is available for the treatment of methamphetamine (METH)-induced neurotoxicity, aerobic exercise is being proposed to improve depressive symptoms and substance abuse outcomes. The present study focuses on the effect of exercise on METH-induced aberrant neurogenesis in the hippocampal dentate gyrus in the context of the blood-brain barrier (BBB) pathology. Mice were administered with METH or saline by i.p. injections for 5 days with an escalating dose regimen. One set of mice was sacrificed 24 h post last injection of METH, and the remaining animals were either subjected to voluntary wheel running (exercised mice) or remained in sedentary housing (sedentary mice). METH administration decreased expression of tight junction (TJ) proteins and increased BBB permeability in the hippocampus. These changes were preserved post METH administration in sedentary mice and were associated with the development of significant aberrations of neural differentiation. Exercise protected against these effects by enhancing the protein expression of TJ proteins, stabilizing the BBB integrity, and enhancing the neural differentiation. In addition, exercise protected against METH-induced systemic increase in inflammatory cytokine levels. These results suggest that exercise can attenuate METH-induced neurotoxicity by protecting against the BBB disruption and related microenvironmental changes in the hippocampus.
Department of Biochemistry and Molecular Biology, Miller School of Medicine at University of Miami, Miami, FL 33136, USA.
Minseon
M
Park
Department of Biochemistry and Molecular Biology, Miller School of Medicine at University of Miami, Miami, FL 33136, USA.
Harry
H
Levine
Department of Biochemistry and Molecular Biology, Miller School of Medicine at University of Miami, Miami, FL 33136, USA.|Jerzy Kukuczka Academy of Physical Education, Katowice, Poland.
Michal
M
Toborek
Eur J Pharmacol. 2015 Apr 5;752:26-33
25678251
Biol Psychiatry. 2006 Jun 15;59(12):1116-27
16631126
Neuropsychopharmacology. 2009 Oct;34(11):2430-41
19571794
J Biol Chem. 2013 Nov 15;288(46):33324-34
24081143
J Comp Neurol. 2000 Oct 2;425(4):479-94
10975875
Clin Pharmacol Ther. 2003 Nov;74(5):475-86
14586388
Synapse. 2007 Apr;61(4):216-20
17230548
J Neural Transm (Vienna). 2011 Nov;118(11):1559-69
21499940
J Pharmacol Exp Ther. 1995 Jul;274(1):90-6
7616454
Mol Neurodegener. 2013 Jun 24;8:22
23799892
Front Mol Neurosci. 2016 Jan 14;8:88
26834555
Nat Neurosci. 1999 Mar;2(3):266-70
10195220
Neuron. 2008 Jan 24;57(2):178-201
18215617
J Neurosci. 2006 Sep 20;26(38):9703-12
16988041
Front Cell Neurosci. 2013 May 14;7:59
23734097
Proc Natl Acad Sci U S A. 2007 Mar 27;104(13):5638-43
17374720
Neurobiol Dis. 2008 Feb;29(2):176-85
17936635
Cell Stem Cell. 2008 Sep 11;3(3):279-88
18786415
Brain Behav Immun. 2010 Mar;24(3):502-11
20035859
Forensic Sci Int. 2001 Feb 15;116(2-3):163-9
11182268
J Cell Sci. 1997 Jul;110 ( Pt 14):1603-13
9247194
Philos Trans R Soc Lond B Biol Sci. 2008 Jan 12;363(1489):123-37
17322003
Int J Mol Sci. 2013 May 24;14(6):11096-112
23708107
J Addict Dis. 2002;21(1):35-44
11831498
PLoS One. 2013;8(2):e56419
23468865
Physiol Behav. 2015 Aug 1;147:38-46
25846839
Contemp Clin Trials. 2014 Jan;37(1):139-47
24291456
Neurobiol Learn Mem. 2013 Jul;103:72-81
23603364
Pharmacol Rev. 2005 Jun;57(2):173-85
15914466
Life Sci. 2014 Feb 27;97(1):37-44
23892199
J Cell Mol Med. 2012 Feb;16(2):362-75
21435178
Science. 2004 May 28;304(5675):1338-40
15060285
J Neurosci. 2010 Apr 28;30(17):5843-54
20427645
J Addict Dis. 2002;21(1):21-34
11831497
Stem Cells. 2014 Jul;32(7):1968-82
24604711
J Neurosci. 2001 Mar 1;21(5):1628-34
11222653
J Neuroinflammation. 2012 Mar 15;9:52
22420994
Fluids Barriers CNS. 2012 Nov 09;9(1):23
23140302
Genes Nutr. 2009 Dec;4(4):271-82
19685256
Neurology. 2000 Mar 28;54(6):1344-9
10746608
Biomater Sci. 2014 Nov;2(11):1562-1573
25530848
PLoS One. 2012;7(3):e33822
22479453
Brain Res. 2013 Jan 15;1490:193-201
23085314
Synapse. 2001 Feb;39(2):161-6
11180503
Hippocampus. 2006;16(3):305-11
16425237
Curr HIV/AIDS Rep. 2005 Nov;2(4):194-9
16343378
Brain Res. 2011 Sep 9;1411:28-40
21803344
Brain Pathol. 2016 Jan;26(1):62-74
25763997
Schizophr Res. 2011 Nov;132(2-3):183-9
21784619
J Neurochem. 2012 Dec;123(6):1041-53
23061411
Brain Res. 2000 Dec 15;886(1-2):47-53
11119686
Neuropsychopharmacology. 2012 Apr;37(5):1275-87
22205547
Cell Tissue Res. 2008 Jan;331(1):211-24
17922142
Nature. 2002 Feb 28;415(6875):1030-4
11875571
Eur J Neurosci. 2003 Nov;18(10):2803-12
14656329
Nat Rev Neurosci. 2011 Nov 03;12(12):723-38
22048062
Biochem Biophys Res Commun. 2015 Aug 7;463(4):811-7
26056010
JAMA. 1967 Jul 31;201(5):305-9
6071725
Mol Brain. 2011 Jun 27;4:28
21708025
Front Neurosci. 2012 Feb 17;6:25
22363255
Methods Cell Biol. 2008;85:243-72
18155466
J Neurochem. 2002 Sep;82(6):1367-75
12354284
Am J Med Genet B Neuropsychiatr Genet. 2017 Jan;174(1):93-112
26879907